World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
12806
World Ranking
3050
National Ranking
1432

Moriya Tsuji publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Moriya Tsuji sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 195 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Moriya Tsuji D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Moriya Tsuji sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Moriya Tsuji is affiliated with the Aaron Diamond AIDS Research Center in the United States. Their research spans multiple areas within medicine and immunology, with a focus on infectious diseases and immune responses.

The main fields of study covered by Moriya Tsuji include:

  • Medicine
  • Immunology and Microbiology

Within these broad fields, their work concentrates on several subfields such as:

  • Immunology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Molecular Biology
  • Oncology

The primary topics addressed by Moriya Tsuji involve:

  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Vaccines and Immunoinformatics Approaches
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Immunotherapy and Biomarkers
  • HIV Research and Treatment
  • Malaria Research and Control

Frequent publication venues for Moriya Tsuji include:

  • Frontiers in Immunology
  • Biomolecules
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccines
  • Cancer Research

Moriya Tsuji has coauthored multiple papers with several researchers, including:

  • Jing Huang
  • Jordana Grazziela Alves Coelho-dos-Reis
  • David D. Ho
  • Lihong Liu
  • Michael T. Yin

Selected recent papers authored or coauthored by Moriya Tsuji are:

  • "An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses," 2022, Science Translational Medicine
  • "Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics," 2020, Frontiers in Immunology
  • "Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice," 2020, Frontiers in Immunology
  • "Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide," 2020, Vaccines
  • "Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model," 2021, Journal for ImmunoTherapy of Cancer

Best Publications

  • Recognition of bacterial glycosphingolipids by natural killer T cells

    Yuki Kinjo;Douglass Wu;Gisen Kim;Guo-Wen Xing

  • Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.

    Yuki Kinjo;Emmanuel Tupin;Douglass Wu;Masakazu Fujio

  • Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-Galactosylceramide

    John Schmieg;Guangli Yang;Richard W. Franck;Moriya Tsuji;Moriya Tsuji

  • A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

    Fikri Yavuz Avci;Xiangming Li;Moriya Tsuji;Dennis Lee Kasper;Dennis Lee Kasper

  • Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

    Yuki Kinjo;Petr Illarionov;José Luis Vela;Bo Pei

  • Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines

    Gloria Gonzalez-Aseguinolaza;Luc Van Kaer;Cornelia C. Bergmann;James M. Wilson

  • The C-Glycoside Analogue of the Immunostimulant α-Galactosylceramide (KRN7000): Synthesis and Striking Enhancement of Activity

    Guangli Yang;John Schmieg;Moriya Tsuji;Richard W. Franck

  • α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria.

    Gloria Gonzalez-Aseguinolaza;Camila de Oliveira;Margaret Tomaska;Seokmann Hong

  • Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR

    Oscar Bruña-Romero;Julius C.R. Hafalla;Gloria González-Aseguinolaza;Gen-ichiro Sano

  • Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells

    Douglass Wu;Guo-Wen Xing;Michael A. Poles;Amir Horowitz

  • Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites

    Moriya Tsuji;Denise Mattei;Ruth S. Nussenzweig;Daniel Eichinger

  • Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice

    Moriya Tsuji;Peter Mombaerts;Peter Mombaerts;Leo Lefrancois;Ruth S. Nussenzweig

  • Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant

    Xiangming Li;Masakazu Fujio;Masakazu Imamura;Douglass Wu

  • Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice

    Shin-ichiro Fujii;Kanako Shimizu;Hiroaki Hemmi;Mikiko Fukui

  • Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.

    Elaine G. Rodrigues;Fidel Zavala;Daniel Eichinger;James M. Wilson;James M. Wilson

  • CD4+ cytolytic T cell clone confers protection against murine malaria.

    Moriya Tsuji;Pedro Romero;Ruth S. Nussenzweig;Fidel P Zavala

  • Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses.

    Alberto Molano;Se Ho Park;Ya Hui Chiu;Sandy Nosseir

  • Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

    Oscar Bruña-Romero;Gloria González-Aseguinolaza;Julius C. R. Hafalla;Moriya Tsuji

  • Structure-Based Discovery of Glycolipids for CD1d-Mediated NKT Cell Activation: Tuning the Adjuvant versus Immunosuppression Activity

    Masakazu Fujio;Douglass Wu;Raquel Garcia-Navarro;David D. Ho

  • Immunization and Infection Change the Number of Recombination Activating Gene (Rag)-Expressing B Cells in the Periphery by Altering Immature Lymphocyte Production

    Hitoshi Nagaoka;Gloria Gonzalez-Aseguinolaza;Moriya Tsuji;Michel C. Nussenzweig;Michel C. Nussenzweig

Frequent Co-Authors

Fidel P Zavala
Fidel P Zavala Johns Hopkins University
Ruth S. Nussenzweig
Ruth S. Nussenzweig New York University
David D. Ho
David D. Ho Columbia University
Chi-Huey Wong
Chi-Huey Wong Scripps Research Institute
Mitchell Kronenberg
Mitchell Kronenberg University of California, San Diego
Dennis L. Kasper
Dennis L. Kasper Harvard University
James M. Wilson
James M. Wilson University of Pennsylvania
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine
Victor Nussenzweig
Victor Nussenzweig New York University
Jonathan P. Schneck
Jonathan P. Schneck Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA often leads students to explore related healthcare fields that complement their knowledge of the immune system. For those interested in clinical practice, pursuing nurse practitioner programs is a popular pathway. Many students look for the easiest np program options to balance rigorous coursework with clinical experience effectively.

Specializing in mental health, Nurse Practitioners can focus on psychiatric care, with a growing number of online options available. Programs ranking among the top pmhnp programs offer valuable clinical placement opportunities, critical for hands-on experience in psychiatric nursing.

Affordability remains a key consideration for many students. Finding the affordable pmhnp programs can make advanced degrees more accessible while maintaining quality education and preparation for certification.

Career prospects for graduates with Doctor of Nursing Practice (DNP) degrees are strong, with salaries reflecting advanced expertise. Understanding how much do dnp nurses make can help prospective students assess the financial benefits of pursuing higher education in nursing fields related to immunology.

Best Scientists Citing Moriya Tsuji

Trending Scientists

Recently Published Articles